Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Indonesia's Medco Energi offers £340 million for UK-listed Ophir

Published 11/01/2019, 14:09
© Reuters.  Indonesia's Medco Energi offers £340 million for UK-listed Ophir

By Noor Zainab Hussain

(Reuters) - Indonesian oil and gas group Medco Energi Internasional Tbk PT (JK:MEDC) said on Friday it could offer 340 million pounds in cash for London-listed Ophir (L:OPHR), which has assets in south-east Asia.

Ophir's shares fell almost 50 percent last year as it failed to find financing for a liquefied natural gas project in Africa's Equatorial Guinea. It expects to write down $300 million on the project and also shift its headquarters from London to Asia, where it bought assets in 2018.

Ophir's current output of 25,000 barrels per day (bpd) of oil equivalent combined with Medco's stated 2018 target of 85,000 bpd of oil equivalent would make Medco, which has been expanding, the seventh largest non-national oil company upstream producer in Southeast Asia, according to energy research firm WoodMac.

"Medco confirms that while discussions with Ophir are continuing, an agreement on a recommended offer has yet to be concluded," Medco said in a statement following its first approach to buy Ophir last month.

Medco said shareholders of Ophir would receive 48.5 pence in cash for each Ophir share, a 46.1 percent premium to Ophir's share price of 33.2 pence on Dec. 28, the last business day before Medco Global announced the possible offer for Ophir.

Under British takeover rules, Medco's fully-owned subsidiary PT Medco Energi Global has until Jan. 28 to make a firm offer or walk away.

GRAPHIC: Ophir Energy boosted by Medco interest - https://tmsnrt.rs/2AHyDUN

In response to Medco's move on Friday, Ophir said the Indonesian company had in October made an unsolicited approach to buy Ophir at an offer price of 58 pence per Ophir share which was reduced to 53.8 pence in December.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ophir said that following the absence of a licence extension on the Africa asset and a decline in oil price, Medco submitted a revised proposal on Dec. 20 of 53.8 pence per Ophir share.

"This morning, Medco submitted an updated possible offer ... and subsequently made a unilateral announcement without any further discussion," Ophir said.

Founded by oil and gas tycoon Arifin Panigoro, Medco has made sizeable acquisitions in recent years, including leading a $2.6 billion (£2 billion) purchase of the Indonesian unit of Newmont Mining Corp (N:NEM) in November 2016. It also operates power plants in Indonesia.

Medco, headquartered in Jakarta, earns the bulk of its revenue from oil and gas operations, mainly in Indonesia. The firm has focussed on expanding its Southeast Asia production and adding to its existing assets in the Middle East and North Africa.

Standard Chartered (LON:STAN) Bank is acting as financial adviser to Medco.

Shares in Ophir, which has a market value of 305 million pounds, were 3.4 percent higher at 44.5 pence at 1138 GMT.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.